Search Results 1331-1340 of 21990 for Inhibition

  1. Pasireotide s.c. in Patients with Post-Bariatric Hypoglycaemia - Mayo Clinic

    Patients who have been treated with SGLT2 inhibitors (glifozins) in the past must have a wash-out period of at least 4 weeks before the start of the run-in ...

  2. A Study to Evaluate TG4050 in Ovarian Carcinoma - Mayo Clinic

    Patient who remains disease free at least 6 months from last prior dose of cytotoxic chemotherapy (maintenance therapy with bevacizumab or a PARP inhibitor is ...

  3. Breast Clinic - Clinical trials

    ... inhibitor. In the phase II part, to evaluate the preliminary antitumor activity of two different doses/regimens of [177Lu]Lu-NeoB in combination with ...

  4. Lisdexamfetamine dimesylate (oral route) - Side effects & dosage - Mayo Clinic

    Do not use this medicine if you or your child is using or have used an MAO inhibitor (MAOI) such as Eldepryl®, Marplan®, Nardil®, or Parnate® within the ...

  5. Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

    Patients may not have received other prior activating immunotherapies (i.e., checkpoint inhibitor therapies). For the purposes of this study monoclonal ...

  6. Osimertinib (oral route) - Side effects & dosage - Mayo Clinic

    This medicine is also used to treat metastatic NSCLC in patients who have already received EGFR tyrosine kinase inhibitor (TKI) treatment, which did not work.

  7. A Dose Escalation Study of BLU-5937 in Unexplained or Refractory Chronic Cough - Mayo Clinic

    combined (estrogen and progestogen containing) or progestogen-only hormonal contraception associated with inhibition of ovulation;; intrauterine device ...

  8. Mirtazapine (oral route) - Side effects & dosage - Mayo Clinic

    ... inhibitor. If you take them together or do not wait 2 weeks, you may develop confusion, agitation, restlessness, stomach or intestinal symptoms, a sudden ...

  9. Monoclonal antibody drugs for cancer: How they work - Mayo Clinic

    Blocking immune system inhibitors. Your body keeps your immune system from being overactive by making proteins that control the activity of the immune ...

  10. A Study to Evaluate Rivaroxaban to Reduce Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients with Acute COVID-19 Infection - Mayo Clinic

    For example, the need for the use of strong cytochrome P450 (CYP) 3A4 inhibitor or inducer per local prescribing information. Received an investigational ...